Global Antacids Market Size study & Forecast, by Formulation Type (Tablet, Powder, Others) By Distribution Channel (Hospital Pharmacies, E-Commerce, Others) and Regional Analysis, 2023-2030

Global Antacids Market Size study & Forecast, by Formulation Type (Tablet, Powder, Others) By Distribution Channel (Hospital Pharmacies, E-Commerce, Others) and Regional Analysis, 2023-2030

Global Antacids Market is valued approximately USD XXX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2023-2030. Antacid is a sort of medicine that aids to reduce stomach acid and alleviates symptoms associated to excess acid. These over-the-counter medications have sodium bicarbonate, calcium, magnesium, or aluminum as active ingredients. They function by combining with stomach acid to create neutral chemicals that can lessen the acidity of the stomach contents. Antacids can therefore be used to treat symptoms including indigestion, heartburn, and acid reflux. Antacids are frequently used to treat symptoms brought on by excessive stomach acid. They aid in balancing the acid that is responsible for the burning in the chest or stomach. The key factor driving the market growth is rising prevalence of acid reflux and GERD, easy availability of OTC antacids, and rise in the demand for antacids among geriatric population that anticipated to support the market growth during forecast period.

Moreover, the rising geriatric population is one of the factors contributing to the growth of the antacids market. As people age, they are more prone to developing gastrointestinal problems such as acid reflux, heartburn, and gastroesophageal reflux disease (GERD). These conditions can cause discomfort and pain in the chest and throat and can also lead to other health complications. Thus, the rising geriatric population is anticipated to support the market growth. According to The World Bank, in 2015, the number of people aged 65 and above in India was 74.61 million and the number reached 95.75 million in 2021. Also, according to the same source, in 2016, the 22% of total population ages 65 and above in Italy and the number is reached 24% in 2021. As a result, the rising geriatric population in the region is anticipated to create a lucrative demand for the market. Additionally, rapidly changing lifestyle of global population is anticipated to create the lucrative opportunity for the market during forecast period. However, the growing number of alternatives in the market for antacids may stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Antacids Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the presence of key market players, availability of well-developed healthcare infrastructure, increase in incidences of heart burn cases, and easy availability of over-the-counter medication in this region. Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as rising geriatric population, growing presence of pharmaceutical companies, increase in healthcare expenditure and rise in awareness among people about heart burn are expected to drive market growth.

Major market player included in this report are:
Abbott Laboratories
Alkem Laboratories Ltd.
Bayer AG
Cipla Ltd
Haleon plc
Infirst Healthcare Inc.
Pfizer Inc.
Prestige Consumer Healthcare Inc.
Reckitt Benckiser Group PLC,
WellSpring Pharmaceutical Corporation
Recent Developments in the Market:
 In June 2022, Zydus Lifesciences received final approval from the United States Food and Drug Administration (FDA) to market Famotidine tablets in the strengths of 20 mg and 40 mg. Famotidine is a histamine H2 receptor blocker. It works by reducing the amount of acid in the stomach.
Global Antacids Market Report Scope:
Historical Data – 2020 - 2021
Base Year for Estimation – 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered - Formulation Type, Distribution Channel, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:

By Formulation Type:
Tablet
Powder
Others
By Distribution Channel:
Hospital Pharmacies
E-Commerce
Others
By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Companies Mentioned

Abbott Laboratories
Alkem Laboratories Ltd.
Bayer AG
Cipla Ltd
Haleon plc
Infirst Healthcare Inc.
Pfizer Inc.
Prestige Consumer Healthcare Inc.
Reckitt Benckiser Group PLC,
WellSpring Pharmaceutical Corporation

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.